Thank you for using rssforward.com! This service has been made possible by all our customers. In order to provide a sustainable, best of the breed RSS to Email experience, we've chosen to keep this as a paid subscription service. If you are satisfied with your free trial, please sign-up today. Subscriptions without a plan would soon be removed. Thank you!
A study conducted by the team of Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute (MHI), has led to the discovery of a new approach to treat aortic valve stenosis through the administration of a compound that prevents valve deterioration and can even reverse the progression of the disease. A condition that is characterized by a narrowing of the aortic valve that affects approximately 150,000 Canadians, aortic valve stenosis is the most common type of heart valve disease in Western countries...
22 Jul, 2013
-
Source: http://www.medicalnewstoday.com/releases/263647.php
--
Manage subscription | Powered by rssforward.com
Post a Comment